Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cance
This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).
| Condition(s) | Surgery, Cancer |
|---|---|
| Status | Recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Summary | This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm). |
| Who can participate | First Registration Inclusion Criteria: * Age \> 18 years at diagnosis * ECOG performance status 0, 1, or 2, defined as Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction 1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work 2. Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours * Patients must have probable (i.e., clinically suspicious) or histologically/cytologically confirmed, primary or recurrent, malignant neoplasm, malignant neuroendocrine tumor, or carcinoma in situ (any stage). Patients undergoing major operations to resect or treat known or suspected malignancies of |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Fox Chase Cancer Center |
| Locations | Philadelphia, Pennsylvania, United States |
| Start date | 2022-10-14 |
| NCT ID | NCT05454280 |
| Official listing | https://clinicaltrials.gov/study/NCT05454280 |